Burlington, Canada

Dustin Little


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dustin Little

Introduction

Dustin Little is a notable inventor based in Burlington, California. He has made significant contributions to the field of biofilm research, particularly through his innovative patents. With a total of two patents to his name, his work focuses on the treatment and prevention of biofilm-related infections.

Latest Patents

Dustin Little's latest patents include methods and uses of soluble bacterial and fungal proteins in inhibiting and dispersing biofilm. These patents detail methods for treating or preventing biofilm-related infections and preventing biofilm formation on indwelling medical devices, implants, and non-medical surfaces. The methods involve administering at least one soluble microbial protein that is encoded by an exopolysaccharide biosynthetic operon or functional gene cluster. The proteins described in his patents comprise a glycosyl hydrolase domain, and the disclosures further provide particular soluble glycosyl hydrolases and compositions thereof.

Career Highlights

Throughout his career, Dustin Little has worked with esteemed organizations such as The Hospital for Sick Children and the Royal Institution for the Advancement of Learning/McGill University. His experience in these institutions has contributed to his expertise in the field of biofilm research and microbial proteins.

Collaborations

Dustin has collaborated with notable colleagues, including Lynne P. Howell and Perrin Baker. These collaborations have likely enriched his research and contributed to the development of his innovative patents.

Conclusion

Dustin Little's work in the field of biofilm research showcases his innovative spirit and dedication to improving medical treatments. His patents reflect a significant advancement in the understanding and management of biofilm-related infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…